Csquare’s rebound has a bookings story, but the IPO gap remains
CSQR’s supplied chart shows $17.52 and +14.73%. Stronger bookings and guidance add context, while losses and the IPO-price gap remain important.
Read the story
CSQR’s supplied chart shows $17.52 and +14.73%. Stronger bookings and guidance add context, while losses and the IPO-price gap remain important.
Read the story
Stock IPOsCsquare, Iambic and Micware feature in a supplied gainers screen. November 9–10 earnings and analyst coverage offer context, with important caveats.

FutureFuel’s stronger sales and narrower loss are encouraging, but cash outflow clouds the recovery. Its next-quarter forecast now needs proof.

iHeartMedia sharply reduced its 2026 profit and cash-flow outlook. Radio advertising weakness and heavy debt help explain concerns behind the IHRT selloff.

Microvast’s sharp snapshot decline follows weaker sales, shrinking margins and an unresolved going-concern warning. Debt refinancing is now a central risk.

The latest supplied CODX snapshot shows $0.45 and a 74.45% gain. India tuberculosis plans, November 10 earnings and convertible financing frame the business story.

Starling Oncology sold off after its quarterly update. Examine the mixed guidance changes and why stronger revenue does not settle the stock's valuation.

CVRx reduced its revenue outlook amid payer and sales-execution problems. Examine the confirmed news, analyst downgrades and risks behind the decline.

AirSculpt lowered its annual outlook after weaker procedure demand. Explore the earnings catalyst, refinancing and risks behind the AIRS selloff.

indie Semiconductor rallied after higher sales and an upbeat revenue outlook. Explore the catalyst, GAAP losses and the next tests for profitability.

Senstar’s quarterly sales and profit supported a sharp SNT rally. Explore the earnings catalyst, margin questions and tests for a lasting improvement.

Clean Energy raised its annual adjusted EBITDA outlook, with higher RNG volumes and tax-credit benefits supporting results. An $8.3 million catch-up complicates the quarterly run rate.